Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 1995

Ozçelik H, Mousses S, Andrulis I L

Abstract excerpt

Recently, several groups have isolated a cell cycle inhibitor gene (CIP1/WAF1) that is highly induced by wild-type, but not mutant forms of the p53 tumor suppressor. To test the hypothesis that p53 regulates CIP1/WAF1 expression in vivo, we evaluated CIP1/WAF1 mRNA expression levels in breast carcinomas from individuals with axillary node-negative disease with and without p53 mutations using quantitative reverse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cell Cycle

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genes, p53

Share to Mutation

Share to Point Mutation

Share to Polymorphism, Single-Stranded Conformational

Share to RNA, Messenger

Source

Identifiers

PMID: 9816061

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.PMID 9816061Read ↗

Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer.Semantic proximity Read ↗

Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation.Semantic proximity Read ↗

p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.Semantic proximity Read ↗

Aberrant promoter hypermethylation of p21 (WAF1/CIP1) gene and its impact on expression and role of polymorphism in the risk of breast cancer.Semantic proximity Read ↗

CIP2A Is Associated with Human Breast Cancer AggressivitySemantic proximity Read ↗

Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors.Semantic proximity Read ↗

WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.Semantic proximity Read ↗

Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.Semantic proximity Read ↗

Absence of WAF1 mutations in a variety of human malignancies.Semantic proximity Read ↗

P21WAF1/Cip1 gene expression in primary human hepatocellular carcinoma and its relationship with P53 gene mutation.Semantic proximity Read ↗

[WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features].Semantic proximity Read ↗

Analysis of p21WAF1/CIP1 in primary bladder tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.